View Older Stories View More Recent Stories

Jan 20, 2026 07:35AM CrowdStrike (CRWD) Reiterated at Overweight by Cantor Fitzgerald: Acquiring Seraphic
Jan 20, 2026 07:34AM Alphabet (GOOGL) Reiterated at Neutral by Cantor Fitzgerald Ahead of Feb EU Deadline
Jan 20, 2026 07:30AM Freshworks (FRSH) Reiterated at Overweight by Cantor Fitzgerald: An Idea for 2026
Jan 20, 2026 07:28AM EastGroup Properties (EGP) Reiterated at Overweight by Cantor Fitzgerald Ahead of 4Q25
Jan 20, 2026 07:27AM Douglas Emmett (DEI) Reiterated at Neutral by Cantor Fitzgerald After Model Update
Jan 20, 2026 07:25AM MKS Instruments (MKSI) Reiterated at Overweight by Cantor Fitzgerald" EPS Upside Likely
Jan 19, 2026 07:32AM Millennial Potash announces $15.25 million private placement offering
Jan 19, 2026 07:30AM Millennial Announces "Bought Deal" Private Placement Life Offering for Proceeds of $15,250,000
Jan 16, 2026 05:08PM Form 424B3 Cantor Fitzgerald Income
Jan 16, 2026 05:08PM Form 424B3 Cantor Fitzgerald Income
Jan 16, 2026 12:06PM Riot Platforms (RIOT) PT Raised to $31 at Cantor Fitzgerald
Jan 16, 2026 07:11AM Capricor Therapeutics (CAPR) Reiterated at Overweight by Cantor Fitzgerald
Jan 16, 2026 07:10AM Cabaletta Bio (CABA) Reiterated at Overweight by Cantor Fitzgerald
Jan 16, 2026 07:08AM Belite Bio (BLTE) Reiterated at Overweight by Cantor Fitzgerald
Jan 16, 2026 07:07AM Arrowhead Pharma (ARWR) Reiterated at Overweight by Cantor Fitzgerald
Jan 16, 2026 07:04AM ArriVent BioPharma (AVBP) Reiterated at Overweight By Cantor Fitzgerald
Jan 16, 2026 07:02AM Apellis Pharmaceuticals (APLS) Reiterated at Overweight by Cantor Fitzgerald
Jan 16, 2026 06:59AM Alnylam Pharmaceuticals (ALNY) Reiterated at Neutral by Cantor Fitzgerald
Jan 16, 2026 06:54AM Vera Therapeutics (VERA) Reiterated at Overweight by Cantor Fitzgerald
Jan 15, 2026 07:20AM Eupraxia Pharmaceuticals (EPRX) PT Raised to $19 at Cantor Fitzgerald
Jan 15, 2026 07:11AM DBV Technologies (DBVT) Reiterated at Overweight by Cantor Fitzgerald
Jan 15, 2026 07:07AM Abeona Therapeutics (ABEO) Reiterated at Overweight by Cantor Fitzgerald
Jan 15, 2026 07:05AM Skye Bioscience (SKYE) Reiterated at Neutral by Cantor Fitzgerald
Jan 14, 2026 11:21PM Chesapeake Gold Announces Filing of Prospectus Supplement in Connection with Previously Announced $15 Million Bought Deal Public Offering
Jan 14, 2026 04:27PM Orchid Island Capital Announces Estimated Fourth Quarter 2025 Results and December 31, 2025 RMBS Portfolio Characteristics
Jan 14, 2026 02:34PM Cantor Fitzgerald on TG Therapeutics (TGTX): 'Stock is at a very attractive valuation right now'
Jan 14, 2026 09:41AM Micron Technology (MU) PT Raised to $450 at Cantor Fitzgerald: Margins Might Be Higher
Jan 14, 2026 07:17AM Water Street Healthcare Partners Invests in Pillr Health
Jan 14, 2026 07:05AM Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald: PT Conservative
Jan 14, 2026 07:04AM uniQure (QURE) Reiterated at Overweight by Cantor Fitzgerald: FDA Feedback Key
Jan 14, 2026 06:59AM Phathom Pharmaceuticals (PHAT) Reiterated at Overweight at Cantor Fitzgerald
Jan 14, 2026 06:57AM Annexon Biosciences (ANNX) Reiterated at Overweight by Cantor Fitzgerald
Jan 14, 2026 06:57AM Capricor Therapeutics (CAPR) Reiterated at Overweight by Cantor Fitzgerald
Jan 14, 2026 06:56AM Axsome Therapeutics (AXSM) Reiterated at Overweight by Cantor Fitzgerald
Jan 14, 2026 06:55AM MindMed (MNMD) Reiterated at Overweight by Cantor Fitzgerald: Will Outperform
Jan 14, 2026 06:09AM Cantor Fitzgerald Downgrades Arthur J. Gallagher (AJG) to Neutral
Jan 13, 2026 12:02PM Strive to acquire Semler Scientific in all-stock deal for bitcoin holdings
Jan 13, 2026 12:02PM Strive, Inc. (Nasdaq: ASST) and Semler Scientific (Nasdaq: SMLR) Announce Shareholder Approval for Acquisition of Semler Scientific
Jan 13, 2026 07:13AM BioCryst Pharma (BCRX) Reiterated at Overweight by Cantor Fitzgerald
Jan 13, 2026 07:11AM Apellis Pharmaceuticals (APLS) Reiterated at Overweight by Cantor Fitzgerald
Jan 13, 2026 07:10AM Netstreit (NTST) Reiterated at Iverweight by Cantor Fitzgerald: Attractive Position
Jan 13, 2026 07:08AM Lexeo Therapeutics (LXEO) Reiterated at Overweight by Cantor Fitzgerald
Jan 13, 2026 07:06AM Mereo BipPharma (MREO) Reiterated at Overweight by Cantor Fitzgerald: High-Risk
Jan 13, 2026 07:04AM Soleno Therapeutics (SLNO) Reiterated at Overweight by Cantor Fitzgerald:Bullish
Jan 13, 2026 07:02AM atai Life Sciences (ATAI) Reiterated at Overweight by Cantor Fitzgerald
Jan 13, 2026 06:59AM Novavax (NVAX) Reiterated at Overweight by Cantor Fitzgerald: Nuvaxovid Sales Good
Jan 13, 2026 06:56AM ASP Isotopes (ASPI) Reiterated at Overweight by Cantor Fitzgerald
Jan 12, 2026 05:08PM Form POS EX Cantor Fitzgerald Income
Jan 12, 2026 08:21AM Klaviyo (KVYO) Reiterated at Overweight at Cantor Fitzgerald: AI Won't Overtake Software
Jan 12, 2026 08:20AM salesforce (CRM) Reiterated at Overweight by Cantor Fitzgerald: Aims for $60bn by FY30
View More Recent Stories View Older Stories